Cargando…
Divergent clonal evolution of a common precursor to mantle cell lymphoma and classic Hodgkin lymphoma
Clonal heterogeneity and evolution of mantle cell lymphoma (MCL) remain unclear despite the progress in our understanding of its biology. Here, we report a 71-yr-old male patient with an aggressive MCL and depict the clonal evolution from initial diagnosis of typical MCL to relapsed blastoid MCL. Du...
Autores principales: | Tashkandi, Hammad, Petrova-Drus, Kseniya, Batlevi, Connie Lee, Arcila, Maria E., Roshal, Mikhail, Sen, Filiz, Yao, Jinjuan, Baik, Jeeyeon, Bilger, Ashley, Singh, Jessica, de Frank, Stephanie, Kumar, Anita, Aryeequaye, Ruth, Zhang, Yanming, Dogan, Ahmet, Xiao, Wenbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913152/ https://www.ncbi.nlm.nih.gov/pubmed/31395597 http://dx.doi.org/10.1101/mcs.a004259 |
Ejemplares similares
-
Case report: Composite mantle cell lymphoma and classical Hodgkin lymphoma
por: Wang, Hongyu, et al.
Publicado: (2023) -
Clonal hematopoiesis in diffuse large B-cell lymphoma: clinical impact and genetic relatedness to lymphoma and therapy-related myeloid neoplasm
por: Liu, Ying, et al.
Publicado: (2022) -
PCR clonality detection in Hodgkin lymphoma
por: Hebeda, K. M., et al.
Publicado: (2009) -
Clonally-Related CD5+ CLL/SLL and CD10+ high grade B-cell lymphoma suggests common neoplastic progenitor with branched disease evolution, with therapeutic implications
por: Kumar, Priyadarshini, et al.
Publicado: (2019) -
Therapeutic Activity of Lenalidomide in Mantle Cell Lymphoma and Indolent Non-Hodgkin's Lymphomas
por: Gunnellini, Marco, et al.
Publicado: (2012)